Search | TVST | ARVO Journals

Showing 1 – 20 of 123

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles December 2018

Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study

PDF

David J. Valent; Wai T. Wong; Emily Y. Chew; Catherine A. Cukras
TAGS: dextromethorphan, eye, macular edema, diabetic
Trans. Vis. Sci. Tech.. 2018; 7(6):24. doi: 10.1167/tvst.7.6.24

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Epigenetic disease mechanisms associated with age-related macular degeneration

Freekje Van Asten; Ximena Corso Diaz; Vijender Chaitankar; Rinki Ratnapriya; Margaret Starostik; Emily Y. Chew; Deborah A. Ferrington; Anand Swaroop

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):370. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Traci E Clemons; Emily Y. Chew; Eleonora M Lad; Glenn J Jaffe; Sina Farsiu; Sarah Duwel; David Cunefare; Dibyendu Mukherji

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1839. doi:

ARVO Annual Meeting Abstract July 2018

Comparison of fluorescein angiography lesion size of choroidal neovascularization associated with age-related macular degeneration in participants and non-participants of the home tele-monitoring study (ForeseeHome Study)

Ramiro S Maldonado; Elvira Agron; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2391. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Katherine Grace Chen; Jason Alvarez; Wai T Wong; Henry Wiley; Emily Y. Chew; Frederick L Ferris; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2423. doi:

ARVO Annual Meeting Abstract July 2018

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Emily Y. Chew; Traci E Clemons; Glenn J Jaffe; Sina Farsiu; eleonora lad; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2605. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal changes in eyes with hydroxychloroquine retinal toxicity

Ali M. Allahdina; Katherine Grace Chen; Jason Alvarez; Wai T Wong; Emily Y. Chew; Catherine A Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3136. doi:

ARVO Annual Meeting Abstract July 2018

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Ferenc B Sallo; Adam M Dubis; Irene Leung; Traci E Clemons; Daniel Pauleikhoff; Emily Y. Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3139. doi:

ARVO Annual Meeting Abstract July 2018

Multimodal adaptive optics SLO/OCT imaging in eyes with geographic atrophy reveals the cellular status of the photoreceptor – retinal pigment epithelium complex

Tao Liu; Zhuolin Liu; HaeWon Jung; Jianfei Liu; Michael Droettboom; Catherine A Cukras; Emily Y. Chew; Wai T Wong; Daniel Hammer; Johnny Tam

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3215. doi:

ARVO Annual Meeting Abstract July 2018

Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs)

Dante Joseph Pieramici; Frank Holz; Jeffrey S. Heier; Srinivas R. Sadda; Brandon G Busbee; Emily Y. Chew; Paul Mitchell; Adnan Tufail; Christopher Brittain; Daniela Ferrara; Sarah Gray; Lee Honigberg; Jillian Martin; Barbara Tong; Jason Ehrlich; Neil M Bressler

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4948. doi:

ARVO Annual Meeting Abstract July 2018

Genetic Interactions between Diet and Oral Supplements in Age-related Macular Degeneration

Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5346. doi:

ARVO Annual Meeting Abstract July 2018

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Tiarnan D L Keenan; Elvira Agron; Amitha Domalpally; Traci E Clemons; Freekje Van Asten; Wai T Wong; Ronald P Danis; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6010. doi:

ARVO Annual Meeting Abstract July 2018

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Susan Vitale; Elvira Agron; Tiarnan Keenan; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6013. doi:

ARVO Annual Meeting Abstract July 2018

Integrative functional genomics of age-related macular degeneration

Rinki Ratnapriya; Kayode Sosina; Margaret Starostik; Madeline Kwicklis; Rebecca J Kapphahn; Ashley Walton; Alexandra Pietraszkiewicz; Sandra Rocio Montezuma; Lars Fritsche; Emily Y. Chew; Goncalo R. Abecasis; Deborah A. Ferrington; Nilanjan Chatterjee; Anand Swaroop

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6025. doi:

ARVO Annual Meeting Abstract July 2018

Association of Diet to the Development of Late AMD in Participants of AREDS

Elvira Agron; Emily Y. Chew; Julie A. Mares; Esther MEZHIBOVSKY; Traci E Clemons; Freekje Van Asten

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2381. doi:

ARVO Annual Meeting Abstract July 2018

Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2

Jeong W Pak; Amitha Domalpally; Elvira Agron; Ronald P Danis; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2422. doi:

ARVO Annual Meeting Abstract July 2018

Clinical Course and Outcomes of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration in AREDS2

Jeannette J Yu; Elvira Agron; Catherine A Cukras; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5548. doi:

ARVO Annual Meeting Abstract July 2018

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Panos George Christakis; Elvira Agron; Michael L Klein; J. Peter Campbell; Frederick L Ferris; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4947. doi:

ARVO Annual Meeting Abstract July 2018

Discovering drug and retinal disease association patterns from electronic medical records: a text mining approach

Shazia Dharssi; Yifan Peng; Robert Leaman; Emily Y. Chew; Zhiyong Lu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4149. doi:

Retina April 2018

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity

PDF

Ali M. Allahdina; Paul F. Stetson; Susan Vitale; Wai T. Wong; Emily Y. Chew; Fredrick L. Ferris III; Paul A. Sieving; Catherine Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(5):1953-1963. doi: 10.1167/iovs.17-22668

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study

Epigenetic disease mechanisms associated with age-related macular degeneration

Longitudinal Structure/Function Correlation Between Microperimetry and OCT Imaging in Type 2 Macular Telangiectasia (MacTel)

Comparison of fluorescein angiography lesion size of choroidal neovascularization associated with age-related macular degeneration in participants and non-participants of the home tele-monitoring study (ForeseeHome Study)

Longitudinal Study of Dark Adaptation as a Functional Outcome Measure for Age-Related Macular Degeneration

Phase 2 Trial of Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2

Longitudinal changes in eyes with hydroxychloroquine retinal toxicity

Assessing photoreceptor degeneration in type 2 idiopathic macular telangiectasia.

Multimodal adaptive optics SLO/OCT imaging in eyes with geographic atrophy reveals the cellular status of the photoreceptor – retinal pigment epithelium complex

Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs)

Genetic Interactions between Diet and Oral Supplements in Age-related Macular Degeneration

Geographic atrophy of age-related macular degeneration in the Age-Related Eye Disease Study 2 (AREDS2): incidence, clinical characteristics and factors influencing growth rate

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Integrative functional genomics of age-related macular degeneration

Association of Diet to the Development of Late AMD in Participants of AREDS

Fundus autofluorescence risk factors for progression of geographic atrophy (GA) in the Age-Related Eye Disease Study 2

Clinical Course and Outcomes of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration in AREDS2

Development of Geographic Atrophy following Untreated Neovascular Age-related Macular Degeneration—Results from AREDS

Discovering drug and retinal disease association patterns from electronic medical records: a text mining approach

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity

To View More...

You must be signed into an individual account to use this feature.